GSK 269962, Tocris Bioscience™

Description

Potent and selective ROCK inhibitor

Potent Rho kinase (ROCK) inhibitor (IC50 values are 1.6 and 4 nM for recombinant human ROCK1 and ROCK2 respectively). Displays greater than 30-fold selectivity for ROCK against a panel of serine/threonine kinases. Induces vasorelaxation in preconstricted rat aorta (IC50 = 35 nM); lowers blood pressure in a rat model of hypertension.

Specifications

Chemical Identifiers

• CAS: 850664-21-0
• Molecular Formula: C29H30N8O5
• Molecular Weight (g/mol): 570.61
• InChI Key: YOVNFNXUCOWYSG-UHFFFAOYSA-N
• Synonym: aminofurazanyl-azabenzimidazole 6n, n-3-2-4-amino-1,2,5-oxadiazol-3-yl-1-ethyl-1h-imidazo 4,5-c pyridin-6-yl oxy phenyl-4-2-morpholin-4-yl ethoxy benzamide, kinome_3843, d02zqs, n-3-2-4-amino-1,2,5-oxadiazol-3-yl-1-ethyl-1h-imidazo 4,5-c pyridin-6-yl oxy phenyl-4-2-4-morpholinyl ethoxy benzamide, n-3-2-4-amino-furazan-3-yl-1-ethyl-1h-imidazo 4,5-c pyridin-6-yl oxy phenyl-4-2-4-morpholinyl ethyl oxy benzamide, n-3-2-4-amino-1,2,5-oxadiazol-3-yl-1-ethylimidazo 5,4-d pyridin-6-yl oxyphenyl-4-2-morpholin-4-ylethoxy benzamide
• PubChem CID: 16095342
• IUPAC Name: N-[3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-6-yl]oxyphenyl]-4-(2-morpholin-4-ylethoxy)benzamide
• SMILES: CCN1C2=CC(=NC=C2N=C1C3=NON=C3N)OC4=CC=CC(=C4)NC(=O)C5=CC=C(C=C5)OCCN6CCOCC6

• Quantity: 50 mg
• Formula Weight: 570.6
• Percent Purity: >99%
• Chemical Name or Material: GSK 269962